All In Biotech

Free tool

FAERS Monitor: Eprontia

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214679 or its brand name (Eprontia, Topiramate). Reports on generic versions are filed under their own applications.

Reports

50,531

Serious

38,698

77% of reports

Hospitalization

14,416

Death reported

5,656

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective7,042
  • off label use5,694
  • headache3,683
  • nausea3,328
  • fatigue3,196
  • product use in unapproved indication2,623
  • pain2,574
  • migraine2,544
  • dizziness2,419
  • seizure2,273
  • condition aggravated2,215
  • diarrhoea2,210
  • vomiting2,190
  • drug intolerance2,143
  • depression1,972

Reports by year received

View as table
YearReports
2004139
2005254
2006207
2007196
2008383
2009775
2010941
20111,213
20121,395
20131,214
20141,551
20152,420
20162,928
20172,678
20183,542
20193,947
20203,671
20213,717
20223,597
20233,911
20244,561
20254,463
20262,823

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,003,628 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
migraineSignal2,54411.410.923,514
drug intoleranceSignal2,1439.49.015,836
seizureSignal2,2738.38.014,456
product use in unapproved indicationSignal2,6234.44.37,000
depressionSignal1,9723.63.53,764
condition aggravatedSignal2,2153.02.93,067
off label useSignal5,6942.72.76,407
headacheSignal3,6832.52.43,249
drug ineffectiveSignal7,0422.22.25,072
dizzinessSignal2,4192.01.91,276
vomiting2,1901.91.91,020
nausea3,3281.81.71,114
pain2,5741.71.7843
fatigue3,1961.71.7977
diarrhoea2,2101.41.4289

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.